Demegestone
Clinical data | |
---|---|
Synonyms | RU-2453 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C21H28O2 |
Molar mass | 312.446 g/mol |
3D model (JSmol) | |
| |
|
WikiDoc Resources for Demegestone |
Articles |
---|
Most recent articles on Demegestone Most cited articles on Demegestone |
Media |
Powerpoint slides on Demegestone |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Demegestone at Clinical Trials.gov Clinical Trials on Demegestone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Demegestone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Demegestone Discussion groups on Demegestone Patient Handouts on Demegestone Directions to Hospitals Treating Demegestone Risk calculators and risk factors for Demegestone
|
Healthcare Provider Resources |
Causes & Risk Factors for Demegestone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Demegestone (INN) (brand name Lutionex), also known as 17-methyl-19-norpregna-4,9-diene-3,20-dione, is a 19-norprogesterone derivative and steroidal progestin which was introduced by Roussel in France in 1974.[1][2] Like other 19-norprogesterone derivatives, it has relatively high affinity for the progesterone receptor and shows little or no activity at other steroid hormone receptors.[3]
See also
References
- ↑ C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary of Pharmacological Agents. CRC Press. pp. 582–. ISBN 978-0-412-46630-4.
- ↑ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 1215–. ISBN 978-0-8155-1856-3.
- ↑ Ian Milsom (2006). Contraception and Family Planning. Elsevier Health Sciences. pp. 102–. ISBN 0-444-51828-2.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Steroids
- Drug